Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease

American Journal of Pathology

Volumn 178, Issue 3, 2011, Pages 1210-1220

  Alvira, Cristina M ^a   Guignabert, Christophe ^a,b   Kim, Yu Mee ^a   Chen, Chihhsin ^a   Wang, Lingli ^a   Duong, Trang T ^c   Yeung, Rae S M ^c   Li, Dean Y ^d   Rabinovitch, Marlene ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; GELATINASE B; LACTOBACILLUS CASEI EXTRACT; NEUTRALIZING ANTIBODY; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; INFLAMMATION; MARFAN SYNDROME; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

EID: 79952744121     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.054     Document Type: Article

References (58)

1. Falcini F: Kawasaki disease. Curr Opin Rheumatol 2006, 18:33-38
2. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004, 114:1708-1733 (Pubitemid 41754943)
3. Sakalihasan N, Limet R, Defawe OD: Abdominal aortic aneurysm. Lancet 2005, 365:1577-1589 (Pubitemid 40615407)
4. Shimizu K, Mitchell RN, Libby P: Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:987-994 (Pubitemid 43732102)
5. Nakamura Y, Yanagawa H, Ojima T, Kawasaki T, Kato H: Cardiac sequelae of Kawasaki disease among recurrent cases. Arch Dis Child 1998, 78:163-165 (Pubitemid 28136202)
6. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117-121
7. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd: Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 2008, 358:2787-2795 (Pubitemid 351930853)
8. Nichols L, Lagana S, Parwani A: Coronary artery aneurysm: a review and hypothesis regarding etiology. Arch Pathol Lab Med 2008, 132: 823-828 (Pubitemid 351632862)
9. DiChiara MR, Kiely JM, Gimbrone MA Jr, Lee ME, Perrella MA, Topper JN: Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J Exp Med 2000, 192:695-704
10. Feinberg MW, Shimizu K, Lebedeva M, Haspel R, Takayama K, Chen Z, Frederick JP, Wang XF, Simon DI, Libby P, Mitchell RN, Jain MK: Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ Res 2004, 94:601-608 (Pubitemid 38387742)
11. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, Kagan HM: Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2. Am J Respir Cell Mol Biol 1994, 11:751-755
12. Kuang PP, Joyce-Brady M, Zhang XH, Jean JC, Goldstein RH: Fibulin- 5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity. Am J Physiol Cell Physiol 2006, 291:C1412-C1421 (Pubitemid 44878613)
13. McGowan SE, Jackson SK, Olson PJ, Parekh T, Gold LI: Exogenous and endogenous transforming growth factors-beta influence elastin gene expression in cultured lung fibroblasts. Am J Respir Cell Mol Biol 1997, 17:25-35 (Pubitemid 127500817)
14. Akool el S, Doller A, Muller R, Gutwein P, Xin C, Huwiler A, Pfeilschifter J, Eberhardt W: Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway. J Biol Chem 2005, 280:39403-39416
15. Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L, Higgins PJ: TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 2006, 312: 1093-1105
16. Dai J, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P, Becquemin JP, Allaire E: Overexpression of transforming growth factor- beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation 2005, 112:1008-1015 (Pubitemid 41170269)
17. Thompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CT: Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci 2006, 1085:59-73 (Pubitemid 47096570)
18. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, Esato K, Hamano K, Matsuzaki M: Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005, 11:1330-1338 (Pubitemid 41752914)
19. Lemaitre V, Soloway PD, D'Armiento J: Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation 2003, 107:333-338 (Pubitemid 36135233)
20. Hui-Yuen JS, Duong TT, Yeung RS: TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006, 176:6294-6301
21. Duong TT, Silverman ED, Bissessar MV, Yeung RS: Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. Int Immunol 2003, 15:79-89 (Pubitemid 36163770)
22. Lau AC, Duong TT, Ito S, Yeung RS: Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease. Arthritis Rheum 2008, 58:854-863 (Pubitemid 351364884)
23. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinovitch M, Shinwell ES, Dixit A: Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice: prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 2008, 294: L3-L14
24. Alvira CM, Abate A, Yang G, Dennery PA, Rabinovitch M: Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation. Am J Respir Crit Care Med 2007, 175:805-815 (Pubitemid 46631792)
25. Jones PL, Crack J, Rabinovitch M: Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 1997, 139:279-293 (Pubitemid 27444098)
26. Rosenkranz ME, Schulte DJ, Agle LM, Wong MH, Zhang W, Ivashkiv L, Doherty TM, Fishbein MC, Lehman TJ, Michelsen KS, Arditi M: TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation 2005, 112:2966-2973 (Pubitemid 41612299)
27. Schulte DJ, Yilmaz A, Shimada K, Fishbein MC, Lowe EL, Chen S, Wong M, Doherty TM, Lehman T, Crother TR, Sorrentino R, Arditi M: Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J Immunol 2009, 183: 5311-5318
28. Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J: Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol 2002, 26:183-188 (Pubitemid 34107871)
29. Jakobsson L, Domogatskaya A, Tryggvason K, Edgar D, Claesson- Welsh L: Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flow. FASEB J 2008, 22:1530-1539 (Pubitemid 351656793)
30. Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH: Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 2003, 23:576-581 (Pubitemid 36438068)
31. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002, 110:625-632 (Pubitemid 34988786)
32. Yamanaka M, Shegogue D, Pei H, Bu S, Bielawska A, Bielawski J, Pettus B, Hannun YA, Obeid L, Trojanowska M: Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. J Biol Chem 2004, 279:53994-54001 (Pubitemid 40053131)
33. Allaire E, Hasenstab D, Kenagy RD, Starcher B, Clowes MM, Clowes AW: Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation 1998, 98:249-255 (Pubitemid 28337616)
34. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nakazawa M, Fukaya T, Baba K, Yutani C: Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int 2004, 46:590-596 (Pubitemid 39423208)
35. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, Nakazawa M: Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 2000, 101:2935-2941 (Pubitemid 30415884)
36. Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y: Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999, 83:337-339 (Pubitemid 29066489)
37. Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S: Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand J Rheumatol 1997, 26:314-317 (Pubitemid 27390763)
38. Jones JA, Beck C, Barbour JR, Zavadzkas JA, Mukherjee R, Spinale FG, Ikonomidis JS: Alterations in aortic cellular constituents during thoracic aortic aneurysm development: myofibroblast-mediated vascular remodeling. Am J Pathol 2009, 175:1746-1756
39. Chung AW, Au Yeung K, Sandor GG, Judge DP, Dietz HC, van Breemen C: Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res 2007, 101:512-522 (Pubitemid 47351231)
40. Ikonomidis JS, Gibson WC, Butler JE, McClister DM, Sweterlitsch SE, Thompson RP, Mukherjee R, Spinale FG: Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms. Circulation 2004, 110: II268 -II273
41. Kaito K, Urayama H, Watanabe G: Doxycycline treatment in a model of early abdominal aortic aneurysm. Surg Today 2003, 33:426-433 (Pubitemid 36648889)
42. Dai Y, Datta S, Novotny M, Hamilton TA: TGFbeta inhibits LPS-induced chemokine mRNA stabilization. Blood 2003, 102:1178-1185 (Pubitemid 36988020)
43. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993, 90:770-774 (Pubitemid 23028947)
44. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A: ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008, 40:35-42
45. Sharma K, McGowan TA, Wang L, Madesh M, Kaspar V, Szalai G, Thomas AP, Hajnoczky G: Inhibition of type I and III IP(3)Rs by TGF-beta is associated with impaired calcium release in mesangial cells. Am J Physiol Renal Physiol 2000, 278:F1022-F1029
46. Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, Sorokin L, Risling M, Cao Y, Tryggvason K: Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002, 22:1194-1202 (Pubitemid 34094855)
47. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U: Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004, 131:1619-1628 (Pubitemid 38559288)
48. Liu X, Wu H, Byrne M, Krane S, Jaenisch R: Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 1997, 94:1852-1856 (Pubitemid 27113925)
49. Rahkonen O, Su M, Hakovirta H, Koskivirta I, Hormuzdi SG, Vuorio E, Bornstein P, Penttinen R: Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture. Circ Res 2004, 94:83-90 (Pubitemid 38064102)
50. Miner JH, Cunningham J, Sanes JR: Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol 1998, 143:1713-1723 (Pubitemid 29006514)
51. Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A: Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 2007, 27:1259-1268 (Pubitemid 46809413)
52. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P: Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999, 99:96-104 (Pubitemid 29035963)
53. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, McConnell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS, Milewicz DM: Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007, 39:1488-1493 (Pubitemid 350191352)
54. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R: Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 1996, 94:1379-1385 (Pubitemid 26307269)
55. Cheung YF, O K, Woo CW, Armstrong S, Siow YL, Chow PC, Cheung EW: Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr 2008, 8:20
56. Cheung YF, Wong SJ, Ho MH: Relationship between carotid intimamedia thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child 2007, 92:43-47 (Pubitemid 46132933)
57. Shifren A, Durmowicz AG, Knutsen RH, Faury G, Mecham RP: Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure. J Appl Physiol 2008, 105:1610-1619
58. Morise T, Takeuchi Y, Takeda R, Karayalcin U, Yachie A, Miyawaki T: Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease. Angiology 1993, 44:719-723 (Pubitemid 23263732)